dc.contributor.author | Castilla Catalán, Jesús | |
dc.contributor.author | Navascués, Ana | |
dc.contributor.author | Casado, Itziar | |
dc.contributor.author | Díaz-González, Jorge | |
dc.contributor.author | Pérez-García, Alejandra | |
dc.contributor.author | Fernandino, Leticia | |
dc.contributor.author | Martínez-Baz, Iván | |
dc.contributor.author | Aguinaga, Aitziber | |
dc.contributor.author | Pozo Sanchez, Francisco | |
dc.contributor.author | Ezpeleta, Carmen | |
dc.date.accessioned | 2019-06-04T11:24:00Z | |
dc.date.available | 2019-06-04T11:24:00Z | |
dc.date.issued | 2017-02 | |
dc.identifier.citation | Euro Surveill. 2017 Feb;22(7). | es_ES |
dc.identifier.issn | 1025-496X | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/7723 | |
dc.description.abstract | The 2016/17 mid-season vaccine effectiveness estimate against influenza A(H3N2) was 15% (95% confidence interval: -11 to 35) in Navarre. Comparing to individuals unvaccinated in the current and four prior seasons, effectiveness was 24% for current and 3-4 prior doses, 61% for current and 1-2 prior doses, 42% for only current vaccination, and 58% for 3-4 prior doses. This suggests moderate effectiveness for different combinations of vaccination in the current and prior seasons. | es_ES |
dc.description.sponsorship | This study was supported by the Horizon 2020 program of the European Commission (agreement 634446); by the I-MOVE (Influenza Monitoring Vaccine Effectiveness in Europe) Network funded by the European Centre for Disease Prevention and Control; by La Caixa Foundation; and by the Carlos III Institute of Health with the European Regional Development Fund (ERDF) (CM15/00119, INT15/00182). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | European Centre for Disease Prevention and Control (ECDC) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.subject | Case control study | es_ES |
dc.subject | Influenza | es_ES |
dc.subject | Influenza vaccine | es_ES |
dc.subject | Influenza-like illness | es_ES |
dc.subject | Repeated vaccination | es_ES |
dc.subject | Vaccine effectiveness | es_ES |
dc.subject.mesh | Adolescent | es_ES |
dc.subject.mesh | Adult | es_ES |
dc.subject.mesh | Aged | es_ES |
dc.subject.mesh | Child | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Influenza A Virus, H3N2 Subtype | es_ES |
dc.subject.mesh | Influenza Vaccines | es_ES |
dc.subject.mesh | Vaccination | es_ES |
dc.subject.mesh | Young Adult | es_ES |
dc.title | Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución-NoComercial-CompartirIgual 4.0 Internacional | * |
dc.identifier.pubmedID | 28230523 | es_ES |
dc.format.volume | 22 | es_ES |
dc.format.number | 7 | es_ES |
dc.identifier.doi | 10.2807/1560-7917.ES.2017.22.7.30465 | es_ES |
dc.contributor.funder | Fundación La Caixa | |
dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1560-7917 | es_ES |
dc.relation.publisherversion | https://doi.org/10.2807/1560-7917.ES.2017.22.7.30465 | es_ES |
dc.identifier.journal | Eurosurveillance | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/634446 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/CM15/00119 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/INT15/00182 | es_ES |
dc.rights.accessRights | open access | es_ES |